Axcelis Corporate Controller Sells: Is ACLS Stock Worth It?
An Axcelis VP Corporate Controller sold 2,574 shares for roughly $422k. This article breaks down what that means, how...
Financial planning can be overwhelming. Find out where to start and set yourself on the path to financial success.
20,577 articlesAn Axcelis VP Corporate Controller sold 2,574 shares for roughly $422k. This article breaks down what that means, how...
A sharp, convincing call led a man to withdraw hundreds of thousands in cash. This guide explains how these scams wor...
A biotech growth stock has surged 70% this year as it heads into pivotal phase 3 data and regulatory steps. Here’s wh...
Is Lilly stock undervalued healthcare? This article breaks down the valuation case, growth catalysts, risks, and a pr...
SpaceX stock surged after its open, then cooled as investors digest fundamentals and macro conditions. This article e...
Could this chip stock be the next Micron? As AI workloads surge, memory players with strong contract pipelines and he...
XRP has tempted investors for years, yet the price has stayed around the $1 mark in 2026. This guide maps two plausi...
Choosing between VNQ and RWO isn’t just about geography. This guide breaks down how US-focused VNQ compares to global...
As Deere (DE) releases its 2026 earnings outlook, investors weigh crop cycles, equipment demand, and margin trends. T...
Intel's shares have surged about 90% in the past year, but the real test lies in whether this comeback can endure thr...
Caterpillar has powered through a demanding cycle, but can its momentum persist into 2026? This guide digs into the d...
As 2025 unfolds, sight sciences (sght) 2025 becomes a focal point for ophthalmology investors. This guide breaks down...